Clinical Trials
15 trialsNCT02892123 2024-11-27
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Jazz Pharmaceuticals
Phase 1 Completed
NCT06137651 2024-04-01
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Northwestern University
Phase 1 Withdrawn
NCT01802970 2021-10-08
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients
Baylor Research Institute
Phase 1 Completed
NCT00075673 2020-07-27
Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
Case Comprehensive Cancer Center
Phase 1 Terminated
NCT01104259 2017-08-10
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
University of Washington
Phase 1 Completed
NCT01155258 2016-06-13
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
University of Southern California
Phase 1 Completed
NCT01238029 2014-11-21
CELAVIE
Sponsor GmbH
Phase 1 Terminated
NCT00724386 2014-03-07
Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer
University of Chicago
Phase 1 Completed
NCT00513058 2014-01-14
Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer
UNICANCER
Phase 1 Completed
NCT01060514 2013-10-30
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Northwestern University
Phase 1 Terminated
NCT00014430 2013-03-14
Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer
Dartmouth-Hitchcock Medical Center
Phase 1 Completed
NCT00153907 2013-02-07
Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00432562 2012-02-23
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
Mast Therapeutics, Inc.
Phase 1 Completed
NCT00706069 2009-12-15
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer
Hellenic Oncology Research Group
Phase 1 Completed
NCT00001944 2008-03-04
Vinorelbine and XR9576 to Treat Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed